As it has been reported that a leptin/adiponectin imbalance plays a particular role in the development of metabolic syndrome and diabetes, both findings are of relevance and may add to the more classical cardiovascular risk factors present in the preterm study cohort [29]. The gene discussed is LEP; the disease is metabolic syndrome.